nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—Pirenzepine—Oxcarbazepine—epilepsy syndrome	0.0455	0.23	CrCrCtD
Olanzapine—CHRM3—epilepsy syndrome	0.0378	0.172	CbGaD
Olanzapine—CHRM1—epilepsy syndrome	0.0352	0.161	CbGaD
Olanzapine—panic disorder—Diazepam—epilepsy syndrome	0.0352	0.117	CpDpCtD
Olanzapine—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0324	0.108	CpDpCtD
Olanzapine—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0324	0.108	CpDpCtD
Olanzapine—Amoxapine—Diazepam—epilepsy syndrome	0.0313	0.158	CrCrCtD
Olanzapine—CHRM2—epilepsy syndrome	0.0288	0.131	CbGaD
Olanzapine—HTR7—epilepsy syndrome	0.0286	0.13	CbGaD
Olanzapine—bipolar disorder—Topiramate—epilepsy syndrome	0.0275	0.0918	CpDpCtD
Olanzapine—Loxapine—Clobazam—epilepsy syndrome	0.0267	0.135	CrCrCtD
Olanzapine—Clozapine—Clonazepam—epilepsy syndrome	0.0251	0.127	CrCrCtD
Olanzapine—Loxapine—Diazepam—epilepsy syndrome	0.0248	0.126	CrCrCtD
Olanzapine—ADRA2A—epilepsy syndrome	0.0246	0.112	CbGaD
Olanzapine—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0245	0.0818	CpDpCtD
Olanzapine—schizophrenia—Lamotrigine—epilepsy syndrome	0.0234	0.078	CpDpCtD
Olanzapine—Clozapine—Clobazam—epilepsy syndrome	0.023	0.116	CrCrCtD
Olanzapine—Clozapine—Diazepam—epilepsy syndrome	0.0213	0.108	CrCrCtD
Olanzapine—panic disorder—Clonazepam—epilepsy syndrome	0.0213	0.0711	CpDpCtD
Olanzapine—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0209	0.0696	CpDpCtD
Olanzapine—bipolar disorder—Clonazepam—epilepsy syndrome	0.0196	0.0654	CpDpCtD
Olanzapine—CYP2C19—epilepsy syndrome	0.0178	0.0809	CbGaD
Olanzapine—schizophrenia—Carbamazepine—epilepsy syndrome	0.0177	0.0591	CpDpCtD
Olanzapine—bipolar disorder—Gabapentin—epilepsy syndrome	0.0158	0.0527	CpDpCtD
Olanzapine—schizophrenia—Valproic Acid—epilepsy syndrome	0.0151	0.0503	CpDpCtD
Olanzapine—HTR2A—epilepsy syndrome	0.0144	0.0656	CbGaD
Olanzapine—schizophrenia—Clonazepam—epilepsy syndrome	0.0142	0.0473	CpDpCtD
Olanzapine—CYP2D6—epilepsy syndrome	0.0132	0.06	CbGaD
Olanzapine—ALB—epilepsy syndrome	0.00985	0.0449	CbGaD
Olanzapine—ABCB1—epilepsy syndrome	0.0094	0.0428	CbGaD
Olanzapine—ALB—Oxcarbazepine—epilepsy syndrome	0.00824	0.0454	CbGbCtD
Olanzapine—ALB—Fosphenytoin—epilepsy syndrome	0.0072	0.0397	CbGbCtD
Olanzapine—ALB—Clonazepam—epilepsy syndrome	0.00651	0.0359	CbGbCtD
Olanzapine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00534	0.0294	CbGbCtD
Olanzapine—ALB—Rufinamide—epilepsy syndrome	0.00531	0.0292	CbGbCtD
Olanzapine—CYP2C19—Trimethadione—epilepsy syndrome	0.00497	0.0274	CbGbCtD
Olanzapine—CYP2C19—Felbamate—epilepsy syndrome	0.00497	0.0274	CbGbCtD
Olanzapine—ABCB1—Levetiracetam—epilepsy syndrome	0.00471	0.026	CbGbCtD
Olanzapine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00467	0.0257	CbGbCtD
Olanzapine—ALB—Phenytoin—epilepsy syndrome	0.00464	0.0256	CbGbCtD
Olanzapine—ALB—Propofol—epilepsy syndrome	0.00433	0.0238	CbGbCtD
Olanzapine—CYP2C9—Trimethadione—epilepsy syndrome	0.00413	0.0227	CbGbCtD
Olanzapine—CYP2C19—Clobazam—epilepsy syndrome	0.00405	0.0223	CbGbCtD
Olanzapine—ALB—Diazepam—epilepsy syndrome	0.00392	0.0216	CbGbCtD
Olanzapine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00388	0.0214	CbGbCtD
Olanzapine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00336	0.0185	CbGbCtD
Olanzapine—ABCB1—Clobazam—epilepsy syndrome	0.00327	0.018	CbGbCtD
Olanzapine—ABCB1—Lamotrigine—epilepsy syndrome	0.00314	0.0173	CbGbCtD
Olanzapine—CYP2C19—Primidone—epilepsy syndrome	0.00313	0.0172	CbGbCtD
Olanzapine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0031	0.017	CbGbCtD
Olanzapine—CYP2C19—Phenytoin—epilepsy syndrome	0.00301	0.0166	CbGbCtD
Olanzapine—CYP1A2—Primidone—epilepsy syndrome	0.00289	0.0159	CbGbCtD
Olanzapine—CYP2C19—Propofol—epilepsy syndrome	0.00281	0.0155	CbGbCtD
Olanzapine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00279	0.0154	CbGbCtD
Olanzapine—ABCB1—Carbamazepine—epilepsy syndrome	0.00271	0.0149	CbGbCtD
Olanzapine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00268	0.0148	CbGbCtD
Olanzapine—CYP2C9—Primidone—epilepsy syndrome	0.0026	0.0143	CbGbCtD
Olanzapine—CYP1A2—Propofol—epilepsy syndrome	0.00259	0.0143	CbGbCtD
Olanzapine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00258	0.0142	CbGbCtD
Olanzapine—CYP2C19—Diazepam—epilepsy syndrome	0.00254	0.014	CbGbCtD
Olanzapine—CYP2C9—Phenytoin—epilepsy syndrome	0.0025	0.0138	CbGbCtD
Olanzapine—CYP2C19—Zonisamide—epilepsy syndrome	0.00248	0.0137	CbGbCtD
Olanzapine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00247	0.0136	CbGbCtD
Olanzapine—ABCB1—Phenytoin—epilepsy syndrome	0.00243	0.0134	CbGbCtD
Olanzapine—CYP3A4—Felbamate—epilepsy syndrome	0.0024	0.0132	CbGbCtD
Olanzapine—CYP3A4—Trimethadione—epilepsy syndrome	0.0024	0.0132	CbGbCtD
Olanzapine—CYP1A2—Diazepam—epilepsy syndrome	0.00235	0.0129	CbGbCtD
Olanzapine—CYP2C9—Propofol—epilepsy syndrome	0.00233	0.0129	CbGbCtD
Olanzapine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00226	0.0124	CbGbCtD
Olanzapine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00223	0.0123	CbGbCtD
Olanzapine—ABCB1—Phenobarbital—epilepsy syndrome	0.00216	0.0119	CbGbCtD
Olanzapine—ABCB1—Midazolam—epilepsy syndrome	0.00213	0.0118	CbGbCtD
Olanzapine—CYP2D6—Propofol—epilepsy syndrome	0.00213	0.0118	CbGbCtD
Olanzapine—CYP2C9—Diazepam—epilepsy syndrome	0.00211	0.0116	CbGbCtD
Olanzapine—ABCB1—Diazepam—epilepsy syndrome	0.00205	0.0113	CbGbCtD
Olanzapine—CYP3A4—Clonazepam—epilepsy syndrome	0.00204	0.0112	CbGbCtD
Olanzapine—CYP2C19—Valproic Acid—epilepsy syndrome	0.002	0.011	CbGbCtD
Olanzapine—CYP3A4—Clobazam—epilepsy syndrome	0.00196	0.0108	CbGbCtD
Olanzapine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00185	0.0102	CbGbCtD
Olanzapine—CYP2C19—Topiramate—epilepsy syndrome	0.00181	0.00996	CbGbCtD
Olanzapine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00167	0.00918	CbGbCtD
Olanzapine—CYP3A4—Rufinamide—epilepsy syndrome	0.00166	0.00917	CbGbCtD
Olanzapine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00162	0.00893	CbGbCtD
Olanzapine—CYP3A4—Primidone—epilepsy syndrome	0.00151	0.00834	CbGbCtD
Olanzapine—CYP3A4—Phenytoin—epilepsy syndrome	0.00145	0.00801	CbGbCtD
Olanzapine—CYP3A4—Propofol—epilepsy syndrome	0.00136	0.00747	CbGbCtD
Olanzapine—CYP3A4—Phenobarbital—epilepsy syndrome	0.0013	0.00714	CbGbCtD
Olanzapine—CYP3A4—Acetazolamide—epilepsy syndrome	0.0013	0.00714	CbGbCtD
Olanzapine—CYP3A4—Midazolam—epilepsy syndrome	0.00128	0.00704	CbGbCtD
Olanzapine—CYP3A4—Diazepam—epilepsy syndrome	0.00123	0.00677	CbGbCtD
Olanzapine—CYP3A4—Zonisamide—epilepsy syndrome	0.0012	0.00661	CbGbCtD
Olanzapine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000969	0.00534	CbGbCtD
Olanzapine—CYP3A4—Topiramate—epilepsy syndrome	0.000874	0.00481	CbGbCtD
Olanzapine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000463	0.0134	CbGeAlD
Olanzapine—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000448	0.013	CbGeAlD
Olanzapine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000444	0.0128	CbGeAlD
Olanzapine—HTR7—pons—epilepsy syndrome	0.000434	0.0125	CbGeAlD
Olanzapine—HTR7—autonomic nervous system—epilepsy syndrome	0.0004	0.0116	CbGeAlD
Olanzapine—HTR2A—cerebellar cortex—epilepsy syndrome	0.000383	0.0111	CbGeAlD
Olanzapine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000373	0.0108	CbGeAlD
Olanzapine—HTR2A—vagus nerve—epilepsy syndrome	0.000359	0.0104	CbGeAlD
Olanzapine—HTR7—telencephalic ventricle—epilepsy syndrome	0.000357	0.0103	CbGeAlD
Olanzapine—DRD1—ganglion—epilepsy syndrome	0.000356	0.0103	CbGeAlD
Olanzapine—HTR3A—ganglion—epilepsy syndrome	0.000343	0.00993	CbGeAlD
Olanzapine—HTR5A—head—epilepsy syndrome	0.000343	0.00992	CbGeAlD
Olanzapine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000337	0.00976	CbGeAlD
Olanzapine—HTR5A—nervous system—epilepsy syndrome	0.000325	0.0094	CbGeAlD
Olanzapine—HTR5A—central nervous system—epilepsy syndrome	0.000313	0.00905	CbGeAlD
Olanzapine—HTR1B—ganglion—epilepsy syndrome	0.000288	0.00833	CbGeAlD
Olanzapine—HTR1D—ganglion—epilepsy syndrome	0.000279	0.00807	CbGeAlD
Olanzapine—HTR2C—ganglion—epilepsy syndrome	0.000276	0.00799	CbGeAlD
Olanzapine—HTR2A—pons—epilepsy syndrome	0.00027	0.00782	CbGeAlD
Olanzapine—HTR1E—brainstem—epilepsy syndrome	0.000265	0.00766	CbGeAlD
Olanzapine—HTR1E—forebrain—epilepsy syndrome	0.000256	0.00739	CbGeAlD
Olanzapine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000249	0.00721	CbGeAlD
Olanzapine—HTR5A—brain—epilepsy syndrome	0.000248	0.00719	CbGeAlD
Olanzapine—Pirenzepine—CHRM1—epilepsy syndrome	0.000236	0.139	CrCbGaD
Olanzapine—HTR1E—telencephalon—epilepsy syndrome	0.000235	0.0068	CbGeAlD
Olanzapine—HTR1A—ganglion—epilepsy syndrome	0.000232	0.00672	CbGeAlD
Olanzapine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000223	0.00644	CbGeAlD
Olanzapine—HTR7—ganglion—epilepsy syndrome	0.000222	0.00643	CbGeAlD
Olanzapine—DRD2—ganglion—epilepsy syndrome	0.00021	0.00608	CbGeAlD
Olanzapine—HTR6—forebrain—epilepsy syndrome	0.000201	0.0058	CbGeAlD
Olanzapine—DRD5—forebrain—epilepsy syndrome	0.000195	0.00565	CbGeAlD
Olanzapine—HTR6—telencephalon—epilepsy syndrome	0.000184	0.00533	CbGeAlD
Olanzapine—DRD5—telencephalon—epilepsy syndrome	0.00018	0.00519	CbGeAlD
Olanzapine—HTR1A—hindbrain—epilepsy syndrome	0.000176	0.0051	CbGeAlD
Olanzapine—HTR7—hindbrain—epilepsy syndrome	0.000169	0.00487	CbGeAlD
Olanzapine—ADRA1A—hindbrain—epilepsy syndrome	0.000163	0.0047	CbGeAlD
Olanzapine—DRD2—hindbrain—epilepsy syndrome	0.000159	0.00461	CbGeAlD
Olanzapine—DRD1—brainstem—epilepsy syndrome	0.000155	0.00447	CbGeAlD
Olanzapine—H1F0—forebrain—epilepsy syndrome	0.000151	0.00437	CbGeAlD
Olanzapine—HTR3A—brainstem—epilepsy syndrome	0.000149	0.00432	CbGeAlD
Olanzapine—DRD1—forebrain—epilepsy syndrome	0.000149	0.00431	CbGeAlD
Olanzapine—HTR1E—head—epilepsy syndrome	0.000146	0.00423	CbGeAlD
Olanzapine—HTR3A—forebrain—epilepsy syndrome	0.000144	0.00417	CbGeAlD
Olanzapine—H1F0—telencephalon—epilepsy syndrome	0.000139	0.00402	CbGeAlD
Olanzapine—HTR1E—nervous system—epilepsy syndrome	0.000139	0.00401	CbGeAlD
Olanzapine—HTR2A—ganglion—epilepsy syndrome	0.000139	0.00401	CbGeAlD
Olanzapine—DRD1—telencephalon—epilepsy syndrome	0.000137	0.00397	CbGeAlD
Olanzapine—HTR1E—central nervous system—epilepsy syndrome	0.000134	0.00386	CbGeAlD
Olanzapine—HTR3A—telencephalon—epilepsy syndrome	0.000132	0.00383	CbGeAlD
Olanzapine—CHRM4—head—epilepsy syndrome	0.000128	0.00371	CbGeAlD
Olanzapine—HTR1B—brainstem—epilepsy syndrome	0.000125	0.00362	CbGeAlD
Olanzapine—DRD4—brain—epilepsy syndrome	0.000123	0.00356	CbGeAlD
Olanzapine—CHRM4—nervous system—epilepsy syndrome	0.000122	0.00352	CbGeAlD
Olanzapine—HTR1D—brainstem—epilepsy syndrome	0.000121	0.00351	CbGeAlD
Olanzapine—HTR1B—forebrain—epilepsy syndrome	0.000121	0.0035	CbGeAlD
Olanzapine—CHRM2—forebrain—epilepsy syndrome	0.00012	0.00348	CbGeAlD
Olanzapine—HTR2C—brainstem—epilepsy syndrome	0.00012	0.00347	CbGeAlD
Olanzapine—DRD3—head—epilepsy syndrome	0.000119	0.00345	CbGeAlD
Olanzapine—FMO3—head—epilepsy syndrome	0.000118	0.00341	CbGeAlD
Olanzapine—CHRM4—central nervous system—epilepsy syndrome	0.000117	0.00339	CbGeAlD
Olanzapine—HTR1D—forebrain—epilepsy syndrome	0.000117	0.00338	CbGeAlD
Olanzapine—HTR2C—forebrain—epilepsy syndrome	0.000116	0.00335	CbGeAlD
Olanzapine—HTR6—head—epilepsy syndrome	0.000115	0.00332	CbGeAlD
Olanzapine—DRD3—nervous system—epilepsy syndrome	0.000113	0.00327	CbGeAlD
Olanzapine—FMO3—nervous system—epilepsy syndrome	0.000112	0.00323	CbGeAlD
Olanzapine—DRD5—head—epilepsy syndrome	0.000112	0.00323	CbGeAlD
Olanzapine—HTR1B—telencephalon—epilepsy syndrome	0.000111	0.00321	CbGeAlD
Olanzapine—CHRM2—telencephalon—epilepsy syndrome	0.000111	0.0032	CbGeAlD
Olanzapine—CHRM1—forebrain—epilepsy syndrome	0.000109	0.00317	CbGeAlD
Olanzapine—H1F0—medulla oblongata—epilepsy syndrome	0.000109	0.00316	CbGeAlD
Olanzapine—DRD3—central nervous system—epilepsy syndrome	0.000109	0.00315	CbGeAlD
Olanzapine—HTR6—nervous system—epilepsy syndrome	0.000109	0.00315	CbGeAlD
Olanzapine—HTR2B—forebrain—epilepsy syndrome	0.000109	0.00315	CbGeAlD
Olanzapine—FMO3—central nervous system—epilepsy syndrome	0.000108	0.00311	CbGeAlD
Olanzapine—HTR1D—telencephalon—epilepsy syndrome	0.000108	0.00311	CbGeAlD
Olanzapine—HTR2C—telencephalon—epilepsy syndrome	0.000107	0.00308	CbGeAlD
Olanzapine—HTR1E—brain—epilepsy syndrome	0.000106	0.00307	CbGeAlD
Olanzapine—DRD5—nervous system—epilepsy syndrome	0.000106	0.00307	CbGeAlD
Olanzapine—HTR2A—hindbrain—epilepsy syndrome	0.000105	0.00304	CbGeAlD
Olanzapine—HRH2—head—epilepsy syndrome	0.000105	0.00304	CbGeAlD
Olanzapine—HTR6—central nervous system—epilepsy syndrome	0.000105	0.00303	CbGeAlD
Olanzapine—DRD5—central nervous system—epilepsy syndrome	0.000102	0.00295	CbGeAlD
Olanzapine—HTR1A—brainstem—epilepsy syndrome	0.000101	0.00292	CbGeAlD
Olanzapine—CHRM1—telencephalon—epilepsy syndrome	0.000101	0.00291	CbGeAlD
Olanzapine—CHRM5—head—epilepsy syndrome	0.0001	0.0029	CbGeAlD
Olanzapine—HTR2B—telencephalon—epilepsy syndrome	0.0001	0.0029	CbGeAlD
Olanzapine—H1F0—midbrain—epilepsy syndrome	9.97e-05	0.00289	CbGeAlD
Olanzapine—HRH2—nervous system—epilepsy syndrome	9.95e-05	0.00288	CbGeAlD
Olanzapine—DRD1—midbrain—epilepsy syndrome	9.85e-05	0.00285	CbGeAlD
Olanzapine—CHRM3—forebrain—epilepsy syndrome	9.79e-05	0.00283	CbGeAlD
Olanzapine—HTR1A—forebrain—epilepsy syndrome	9.75e-05	0.00282	CbGeAlD
Olanzapine—H1F0—spinal cord—epilepsy syndrome	9.73e-05	0.00282	CbGeAlD
Olanzapine—HTR7—brainstem—epilepsy syndrome	9.66e-05	0.00279	CbGeAlD
Olanzapine—HRH2—central nervous system—epilepsy syndrome	9.58e-05	0.00277	CbGeAlD
Olanzapine—CYP2D6—hindbrain—epilepsy syndrome	9.57e-05	0.00277	CbGeAlD
Olanzapine—CHRM5—nervous system—epilepsy syndrome	9.51e-05	0.00275	CbGeAlD
Olanzapine—HTR7—forebrain—epilepsy syndrome	9.32e-05	0.0027	CbGeAlD
Olanzapine—ADRA1A—brainstem—epilepsy syndrome	9.32e-05	0.00269	CbGeAlD
Olanzapine—CHRM4—brain—epilepsy syndrome	9.3e-05	0.00269	CbGeAlD
Olanzapine—ADRA1B—head—epilepsy syndrome	9.16e-05	0.00265	CbGeAlD
Olanzapine—CHRM5—central nervous system—epilepsy syndrome	9.15e-05	0.00265	CbGeAlD
Olanzapine—Clozapine—HRH3—epilepsy syndrome	9.15e-05	0.0541	CrCbGaD
Olanzapine—DRD2—brainstem—epilepsy syndrome	9.13e-05	0.00264	CbGeAlD
Olanzapine—CHRM3—telencephalon—epilepsy syndrome	9e-05	0.0026	CbGeAlD
Olanzapine—ADRA1A—forebrain—epilepsy syndrome	8.99e-05	0.0026	CbGeAlD
Olanzapine—HTR1A—telencephalon—epilepsy syndrome	8.97e-05	0.00259	CbGeAlD
Olanzapine—DRD2—forebrain—epilepsy syndrome	8.81e-05	0.00255	CbGeAlD
Olanzapine—ADRA1B—nervous system—epilepsy syndrome	8.69e-05	0.00251	CbGeAlD
Olanzapine—H1F0—head—epilepsy syndrome	8.65e-05	0.0025	CbGeAlD
Olanzapine—DRD3—brain—epilepsy syndrome	8.64e-05	0.0025	CbGeAlD
Olanzapine—HTR7—telencephalon—epilepsy syndrome	8.57e-05	0.00248	CbGeAlD
Olanzapine—FMO3—brain—epilepsy syndrome	8.55e-05	0.00247	CbGeAlD
Olanzapine—DRD1—head—epilepsy syndrome	8.54e-05	0.00247	CbGeAlD
Olanzapine—HTR2C—medulla oblongata—epilepsy syndrome	8.37e-05	0.00242	CbGeAlD
Olanzapine—ADRA1B—central nervous system—epilepsy syndrome	8.36e-05	0.00242	CbGeAlD
Olanzapine—Amoxapine—GABRA1—epilepsy syndrome	8.36e-05	0.0494	CrCbGaD
Olanzapine—HTR6—brain—epilepsy syndrome	8.32e-05	0.00241	CbGeAlD
Olanzapine—ORM1—spinal cord—epilepsy syndrome	8.31e-05	0.0024	CbGeAlD
Olanzapine—ADRA1A—telencephalon—epilepsy syndrome	8.27e-05	0.00239	CbGeAlD
Olanzapine—HTR3A—head—epilepsy syndrome	8.25e-05	0.00239	CbGeAlD
Olanzapine—H1F0—nervous system—epilepsy syndrome	8.2e-05	0.00237	CbGeAlD
Olanzapine—DRD2—telencephalon—epilepsy syndrome	8.1e-05	0.00234	CbGeAlD
Olanzapine—DRD5—brain—epilepsy syndrome	8.1e-05	0.00234	CbGeAlD
Olanzapine—DRD1—nervous system—epilepsy syndrome	8.1e-05	0.00234	CbGeAlD
Olanzapine—HTR1B—midbrain—epilepsy syndrome	7.98e-05	0.00231	CbGeAlD
Olanzapine—H1F0—central nervous system—epilepsy syndrome	7.89e-05	0.00228	CbGeAlD
Olanzapine—ADRA2C—telencephalon—epilepsy syndrome	7.88e-05	0.00228	CbGeAlD
Olanzapine—HTR3A—nervous system—epilepsy syndrome	7.82e-05	0.00226	CbGeAlD
Olanzapine—DRD1—central nervous system—epilepsy syndrome	7.8e-05	0.00226	CbGeAlD
Olanzapine—Amoxapine—CHRM1—epilepsy syndrome	7.79e-05	0.0461	CrCbGaD
Olanzapine—HTR1B—spinal cord—epilepsy syndrome	7.79e-05	0.00225	CbGeAlD
Olanzapine—HTR1D—midbrain—epilepsy syndrome	7.73e-05	0.00224	CbGeAlD
Olanzapine—H1F0—cerebellum—epilepsy syndrome	7.72e-05	0.00223	CbGeAlD
Olanzapine—HTR2C—midbrain—epilepsy syndrome	7.65e-05	0.00221	CbGeAlD
Olanzapine—HRH2—brain—epilepsy syndrome	7.61e-05	0.0022	CbGeAlD
Olanzapine—HTR3A—central nervous system—epilepsy syndrome	7.53e-05	0.00218	CbGeAlD
Olanzapine—HTR2C—spinal cord—epilepsy syndrome	7.47e-05	0.00216	CbGeAlD
Olanzapine—CHRM5—brain—epilepsy syndrome	7.27e-05	0.0021	CbGeAlD
Olanzapine—ORM1—nervous system—epilepsy syndrome	7e-05	0.00202	CbGeAlD
Olanzapine—HRH1—forebrain—epilepsy syndrome	6.96e-05	0.00201	CbGeAlD
Olanzapine—HTR1B—head—epilepsy syndrome	6.92e-05	0.002	CbGeAlD
Olanzapine—CHRM2—head—epilepsy syndrome	6.88e-05	0.00199	CbGeAlD
Olanzapine—ADRA2A—forebrain—epilepsy syndrome	6.84e-05	0.00198	CbGeAlD
Olanzapine—ORM1—central nervous system—epilepsy syndrome	6.74e-05	0.00195	CbGeAlD
Olanzapine—HTR7—medulla oblongata—epilepsy syndrome	6.73e-05	0.00195	CbGeAlD
Olanzapine—HTR1D—head—epilepsy syndrome	6.7e-05	0.00194	CbGeAlD
Olanzapine—ADRA1B—brain—epilepsy syndrome	6.64e-05	0.00192	CbGeAlD
Olanzapine—HTR2C—head—epilepsy syndrome	6.63e-05	0.00192	CbGeAlD
Olanzapine—HTR1B—nervous system—epilepsy syndrome	6.56e-05	0.0019	CbGeAlD
Olanzapine—Loxapine—CHRM3—epilepsy syndrome	6.53e-05	0.0386	CrCbGaD
Olanzapine—CHRM2—nervous system—epilepsy syndrome	6.53e-05	0.00189	CbGeAlD
Olanzapine—HTR1A—midbrain—epilepsy syndrome	6.44e-05	0.00186	CbGeAlD
Olanzapine—HRH1—telencephalon—epilepsy syndrome	6.4e-05	0.00185	CbGeAlD
Olanzapine—Quetiapine—CHRM3—epilepsy syndrome	6.37e-05	0.0376	CrCbGaD
Olanzapine—HTR1D—nervous system—epilepsy syndrome	6.35e-05	0.00184	CbGeAlD
Olanzapine—Amoxapine—HTR7—epilepsy syndrome	6.33e-05	0.0374	CrCbGaD
Olanzapine—HTR1B—central nervous system—epilepsy syndrome	6.32e-05	0.00183	CbGeAlD
Olanzapine—HTR2C—nervous system—epilepsy syndrome	6.29e-05	0.00182	CbGeAlD
Olanzapine—ADRA2A—telencephalon—epilepsy syndrome	6.29e-05	0.00182	CbGeAlD
Olanzapine—HTR1A—spinal cord—epilepsy syndrome	6.28e-05	0.00182	CbGeAlD
Olanzapine—CHRM2—central nervous system—epilepsy syndrome	6.28e-05	0.00182	CbGeAlD
Olanzapine—H1F0—brain—epilepsy syndrome	6.27e-05	0.00181	CbGeAlD
Olanzapine—CHRM1—head—epilepsy syndrome	6.27e-05	0.00181	CbGeAlD
Olanzapine—HTR2B—head—epilepsy syndrome	6.23e-05	0.0018	CbGeAlD
Olanzapine—ADRA2C—medulla oblongata—epilepsy syndrome	6.19e-05	0.00179	CbGeAlD
Olanzapine—DRD1—brain—epilepsy syndrome	6.19e-05	0.00179	CbGeAlD
Olanzapine—HTR7—midbrain—epilepsy syndrome	6.16e-05	0.00178	CbGeAlD
Olanzapine—HTR1D—central nervous system—epilepsy syndrome	6.12e-05	0.00177	CbGeAlD
Olanzapine—Loxapine—CHRM1—epilepsy syndrome	6.09e-05	0.036	CrCbGaD
Olanzapine—HTR2C—central nervous system—epilepsy syndrome	6.06e-05	0.00175	CbGeAlD
Olanzapine—HTR2A—brainstem—epilepsy syndrome	6.02e-05	0.00174	CbGeAlD
Olanzapine—HTR7—spinal cord—epilepsy syndrome	6.01e-05	0.00174	CbGeAlD
Olanzapine—HTR3A—brain—epilepsy syndrome	5.98e-05	0.00173	CbGeAlD
Olanzapine—Quetiapine—CHRM1—epilepsy syndrome	5.94e-05	0.0351	CrCbGaD
Olanzapine—CHRM1—nervous system—epilepsy syndrome	5.94e-05	0.00172	CbGeAlD
Olanzapine—HTR2B—nervous system—epilepsy syndrome	5.91e-05	0.00171	CbGeAlD
Olanzapine—DRD2—midbrain—epilepsy syndrome	5.82e-05	0.00168	CbGeAlD
Olanzapine—HTR2A—forebrain—epilepsy syndrome	5.81e-05	0.00168	CbGeAlD
Olanzapine—CHRM1—central nervous system—epilepsy syndrome	5.72e-05	0.00165	CbGeAlD
Olanzapine—HTR2B—central nervous system—epilepsy syndrome	5.69e-05	0.00165	CbGeAlD
Olanzapine—ADRA2C—midbrain—epilepsy syndrome	5.66e-05	0.00164	CbGeAlD
Olanzapine—CHRM3—head—epilepsy syndrome	5.61e-05	0.00162	CbGeAlD
Olanzapine—HTR1A—head—epilepsy syndrome	5.58e-05	0.00162	CbGeAlD
Olanzapine—ADRA2C—spinal cord—epilepsy syndrome	5.52e-05	0.0016	CbGeAlD
Olanzapine—CYP2D6—brainstem—epilepsy syndrome	5.49e-05	0.00159	CbGeAlD
Olanzapine—Clozapine—CHRM3—epilepsy syndrome	5.48e-05	0.0324	CrCbGaD
Olanzapine—Amoxapine—ADRA2A—epilepsy syndrome	5.43e-05	0.0321	CrCbGaD
Olanzapine—HTR2A—telencephalon—epilepsy syndrome	5.34e-05	0.00155	CbGeAlD
Olanzapine—HTR7—head—epilepsy syndrome	5.34e-05	0.00154	CbGeAlD
Olanzapine—CHRM3—nervous system—epilepsy syndrome	5.32e-05	0.00154	CbGeAlD
Olanzapine—CYP2D6—forebrain—epilepsy syndrome	5.3e-05	0.00153	CbGeAlD
Olanzapine—HTR1A—nervous system—epilepsy syndrome	5.29e-05	0.00153	CbGeAlD
Olanzapine—ADRA1A—head—epilepsy syndrome	5.15e-05	0.00149	CbGeAlD
Olanzapine—CHRM3—central nervous system—epilepsy syndrome	5.12e-05	0.00148	CbGeAlD
Olanzapine—Clozapine—CHRM1—epilepsy syndrome	5.11e-05	0.0302	CrCbGaD
Olanzapine—HTR1A—central nervous system—epilepsy syndrome	5.1e-05	0.00147	CbGeAlD
Olanzapine—HTR7—nervous system—epilepsy syndrome	5.06e-05	0.00146	CbGeAlD
Olanzapine—DRD2—head—epilepsy syndrome	5.05e-05	0.00146	CbGeAlD
Olanzapine—HTR1B—brain—epilepsy syndrome	5.01e-05	0.00145	CbGeAlD
Olanzapine—CHRM2—brain—epilepsy syndrome	4.99e-05	0.00144	CbGeAlD
Olanzapine—HTR1A—cerebellum—epilepsy syndrome	4.98e-05	0.00144	CbGeAlD
Olanzapine—Loxapine—CHRM2—epilepsy syndrome	4.97e-05	0.0294	CrCbGaD
Olanzapine—Loxapine—HTR7—epilepsy syndrome	4.95e-05	0.0292	CrCbGaD
Olanzapine—ADRA2A—medulla oblongata—epilepsy syndrome	4.94e-05	0.00143	CbGeAlD
Olanzapine—ADRA2C—head—epilepsy syndrome	4.91e-05	0.00142	CbGeAlD
Olanzapine—ADRA1A—nervous system—epilepsy syndrome	4.88e-05	0.00141	CbGeAlD
Olanzapine—HTR7—central nervous system—epilepsy syndrome	4.87e-05	0.00141	CbGeAlD
Olanzapine—CYP2D6—telencephalon—epilepsy syndrome	4.87e-05	0.00141	CbGeAlD
Olanzapine—HTR1D—brain—epilepsy syndrome	4.86e-05	0.0014	CbGeAlD
Olanzapine—Quetiapine—CHRM2—epilepsy syndrome	4.85e-05	0.0287	CrCbGaD
Olanzapine—Quetiapine—HTR7—epilepsy syndrome	4.83e-05	0.0285	CrCbGaD
Olanzapine—HTR2C—brain—epilepsy syndrome	4.81e-05	0.00139	CbGeAlD
Olanzapine—DRD2—nervous system—epilepsy syndrome	4.78e-05	0.00138	CbGeAlD
Olanzapine—HTR7—cerebellum—epilepsy syndrome	4.76e-05	0.00138	CbGeAlD
Olanzapine—ADRA1A—central nervous system—epilepsy syndrome	4.7e-05	0.00136	CbGeAlD
Olanzapine—ALB—brain—epilepsy syndrome	4.69e-05	0.00136	CbGeAlD
Olanzapine—ADRA2C—nervous system—epilepsy syndrome	4.65e-05	0.00135	CbGeAlD
Olanzapine—DRD2—central nervous system—epilepsy syndrome	4.61e-05	0.00133	CbGeAlD
Olanzapine—ADRA1A—cerebellum—epilepsy syndrome	4.59e-05	0.00133	CbGeAlD
Olanzapine—CHRM1—brain—epilepsy syndrome	4.54e-05	0.00131	CbGeAlD
Olanzapine—HTR2B—brain—epilepsy syndrome	4.52e-05	0.00131	CbGeAlD
Olanzapine—ADRA2A—midbrain—epilepsy syndrome	4.51e-05	0.00131	CbGeAlD
Olanzapine—DRD2—cerebellum—epilepsy syndrome	4.5e-05	0.0013	CbGeAlD
Olanzapine—ADRA2C—central nervous system—epilepsy syndrome	4.48e-05	0.0013	CbGeAlD
Olanzapine—ADRA2A—spinal cord—epilepsy syndrome	4.4e-05	0.00127	CbGeAlD
Olanzapine—ADRA2C—cerebellum—epilepsy syndrome	4.38e-05	0.00127	CbGeAlD
Olanzapine—Loxapine—ADRA2A—epilepsy syndrome	4.24e-05	0.0251	CrCbGaD
Olanzapine—HTR2A—medulla oblongata—epilepsy syndrome	4.2e-05	0.00121	CbGeAlD
Olanzapine—Clozapine—CHRM2—epilepsy syndrome	4.17e-05	0.0247	CrCbGaD
Olanzapine—Clozapine—HTR7—epilepsy syndrome	4.15e-05	0.0245	CrCbGaD
Olanzapine—Amoxapine—SLC6A4—epilepsy syndrome	4.14e-05	0.0245	CrCbGaD
Olanzapine—Quetiapine—ADRA2A—epilepsy syndrome	4.14e-05	0.0245	CrCbGaD
Olanzapine—CHRM3—brain—epilepsy syndrome	4.06e-05	0.00118	CbGeAlD
Olanzapine—HTR1A—brain—epilepsy syndrome	4.05e-05	0.00117	CbGeAlD
Olanzapine—HRH1—head—epilepsy syndrome	3.98e-05	0.00115	CbGeAlD
Olanzapine—ADRA2A—head—epilepsy syndrome	3.91e-05	0.00113	CbGeAlD
Olanzapine—HTR7—brain—epilepsy syndrome	3.87e-05	0.00112	CbGeAlD
Olanzapine—HTR2A—midbrain—epilepsy syndrome	3.84e-05	0.00111	CbGeAlD
Olanzapine—ABCB1—forebrain—epilepsy syndrome	3.81e-05	0.0011	CbGeAlD
Olanzapine—HRH1—nervous system—epilepsy syndrome	3.78e-05	0.00109	CbGeAlD
Olanzapine—HTR2A—spinal cord—epilepsy syndrome	3.74e-05	0.00108	CbGeAlD
Olanzapine—ADRA1A—brain—epilepsy syndrome	3.73e-05	0.00108	CbGeAlD
Olanzapine—ADRA2A—nervous system—epilepsy syndrome	3.71e-05	0.00107	CbGeAlD
Olanzapine—DRD2—brain—epilepsy syndrome	3.66e-05	0.00106	CbGeAlD
Olanzapine—HRH1—central nervous system—epilepsy syndrome	3.64e-05	0.00105	CbGeAlD
Olanzapine—ADRA2A—central nervous system—epilepsy syndrome	3.57e-05	0.00103	CbGeAlD
Olanzapine—Clozapine—ADRA2A—epilepsy syndrome	3.56e-05	0.021	CrCbGaD
Olanzapine—ADRA2C—brain—epilepsy syndrome	3.55e-05	0.00103	CbGeAlD
Olanzapine—ABCB1—telencephalon—epilepsy syndrome	3.5e-05	0.00101	CbGeAlD
Olanzapine—ADRA2A—cerebellum—epilepsy syndrome	3.49e-05	0.00101	CbGeAlD
Olanzapine—HTR2A—head—epilepsy syndrome	3.33e-05	0.000963	CbGeAlD
Olanzapine—Loxapine—SLC6A4—epilepsy syndrome	3.24e-05	0.0191	CrCbGaD
Olanzapine—Amoxapine—HTR2A—epilepsy syndrome	3.18e-05	0.0188	CrCbGaD
Olanzapine—HTR2A—nervous system—epilepsy syndrome	3.16e-05	0.000913	CbGeAlD
Olanzapine—HTR2A—central nervous system—epilepsy syndrome	3.04e-05	0.000879	CbGeAlD
Olanzapine—CYP2D6—head—epilepsy syndrome	3.03e-05	0.000877	CbGeAlD
Olanzapine—Quetiapine—CYP2C19—epilepsy syndrome	2.99e-05	0.0177	CrCbGaD
Olanzapine—HTR2A—cerebellum—epilepsy syndrome	2.97e-05	0.000859	CbGeAlD
Olanzapine—CYP3A4—nervous system—epilepsy syndrome	2.92e-05	0.000845	CbGeAlD
Olanzapine—Amoxapine—CYP2D6—epilepsy syndrome	2.91e-05	0.0172	CrCbGaD
Olanzapine—HRH1—brain—epilepsy syndrome	2.89e-05	0.000835	CbGeAlD
Olanzapine—CYP2D6—nervous system—epilepsy syndrome	2.87e-05	0.000832	CbGeAlD
Olanzapine—ADRA2A—brain—epilepsy syndrome	2.84e-05	0.000821	CbGeAlD
Olanzapine—CYP3A4—central nervous system—epilepsy syndrome	2.81e-05	0.000814	CbGeAlD
Olanzapine—CYP2D6—central nervous system—epilepsy syndrome	2.77e-05	0.000801	CbGeAlD
Olanzapine—ABCB1—medulla oblongata—epilepsy syndrome	2.75e-05	0.000796	CbGeAlD
Olanzapine—CYP2D6—cerebellum—epilepsy syndrome	2.71e-05	0.000782	CbGeAlD
Olanzapine—Clozapine—CYP2C19—epilepsy syndrome	2.58e-05	0.0152	CrCbGaD
Olanzapine—ABCB1—midbrain—epilepsy syndrome	2.52e-05	0.000728	CbGeAlD
Olanzapine—Loxapine—HTR2A—epilepsy syndrome	2.49e-05	0.0147	CrCbGaD
Olanzapine—ABCB1—spinal cord—epilepsy syndrome	2.45e-05	0.00071	CbGeAlD
Olanzapine—Quetiapine—HTR2A—epilepsy syndrome	2.43e-05	0.0143	CrCbGaD
Olanzapine—HTR2A—brain—epilepsy syndrome	2.41e-05	0.000698	CbGeAlD
Olanzapine—Quetiapine—CYP2D6—epilepsy syndrome	2.22e-05	0.0131	CrCbGaD
Olanzapine—CYP2D6—brain—epilepsy syndrome	2.2e-05	0.000636	CbGeAlD
Olanzapine—ABCB1—head—epilepsy syndrome	2.18e-05	0.000631	CbGeAlD
Olanzapine—Clozapine—HTR2A—epilepsy syndrome	2.09e-05	0.0123	CrCbGaD
Olanzapine—ABCB1—nervous system—epilepsy syndrome	2.07e-05	0.000598	CbGeAlD
Olanzapine—ABCB1—central nervous system—epilepsy syndrome	1.99e-05	0.000576	CbGeAlD
Olanzapine—ABCB1—cerebellum—epilepsy syndrome	1.95e-05	0.000563	CbGeAlD
Olanzapine—Clozapine—CYP2D6—epilepsy syndrome	1.91e-05	0.0113	CrCbGaD
Olanzapine—Quetiapine—ABCB1—epilepsy syndrome	1.58e-05	0.00937	CrCbGaD
Olanzapine—ABCB1—brain—epilepsy syndrome	1.58e-05	0.000457	CbGeAlD
Olanzapine—Clozapine—ABCB1—epilepsy syndrome	1.36e-05	0.00806	CrCbGaD
Olanzapine—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	3.53e-07	5.44e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	3.51e-07	5.42e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	3.51e-07	5.41e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	3.51e-07	5.41e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.5e-07	5.4e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	3.5e-07	5.4e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	3.5e-07	5.39e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	3.49e-07	5.39e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	3.49e-07	5.38e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.48e-07	5.37e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.48e-07	5.36e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	3.48e-07	5.36e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.47e-07	5.35e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.46e-07	5.34e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.46e-07	5.33e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	3.45e-07	5.33e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	3.44e-07	5.31e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—SRC—epilepsy syndrome	3.44e-07	5.31e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.43e-07	5.29e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.43e-07	5.29e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	3.42e-07	5.27e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.42e-07	5.27e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	3.41e-07	5.26e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	3.41e-07	5.25e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.4e-07	5.24e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	3.4e-07	5.24e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	3.39e-07	5.23e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.38e-07	5.21e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.37e-07	5.2e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	3.37e-07	5.2e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	3.36e-07	5.18e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	3.35e-07	5.17e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	3.33e-07	5.13e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	3.32e-07	5.11e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	3.31e-07	5.1e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	3.31e-07	5.1e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	3.29e-07	5.07e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	3.28e-07	5.06e-06	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	3.27e-07	5.05e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.27e-07	5.04e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	3.26e-07	5.03e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.25e-07	5.02e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	3.25e-07	5.01e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	3.25e-07	5.01e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	3.23e-07	4.98e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	3.22e-07	4.96e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	3.22e-07	4.96e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.21e-07	4.96e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.21e-07	4.95e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	3.21e-07	4.94e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.2e-07	4.94e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.2e-07	4.93e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.2e-07	4.93e-06	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.2e-07	4.93e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AGT—epilepsy syndrome	3.19e-07	4.92e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.18e-07	4.9e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	3.17e-07	4.88e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	3.17e-07	4.88e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	3.17e-07	4.88e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	3.16e-07	4.87e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.15e-07	4.85e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.14e-07	4.84e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.13e-07	4.82e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOE—epilepsy syndrome	3.13e-07	4.82e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.12e-07	4.82e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	3.1e-07	4.78e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.1e-07	4.78e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	3.1e-07	4.77e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.09e-07	4.76e-06	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.09e-07	4.76e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	3.08e-07	4.74e-06	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.07e-07	4.73e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—POMC—epilepsy syndrome	3.06e-07	4.72e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	3.06e-07	4.72e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	3.06e-07	4.71e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.05e-07	4.71e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	3.04e-07	4.69e-06	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—AKT1—epilepsy syndrome	3.03e-07	4.67e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.02e-07	4.66e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	3.02e-07	4.65e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TH—epilepsy syndrome	3.01e-07	4.64e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.01e-07	4.63e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	2.99e-07	4.62e-06	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	2.99e-07	4.61e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.98e-07	4.59e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	2.98e-07	4.59e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	2.98e-07	4.59e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	2.97e-07	4.58e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	2.96e-07	4.56e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	2.96e-07	4.56e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.95e-07	4.54e-06	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.94e-07	4.53e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	2.93e-07	4.52e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	2.92e-07	4.51e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.92e-07	4.5e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	2.92e-07	4.5e-06	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	2.92e-07	4.5e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.91e-07	4.49e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	2.91e-07	4.49e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.9e-07	4.48e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.9e-07	4.48e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.9e-07	4.48e-06	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	2.9e-07	4.47e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	2.89e-07	4.46e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.88e-07	4.43e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	2.88e-07	4.43e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	2.87e-07	4.43e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	2.87e-07	4.43e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	2.87e-07	4.43e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	2.87e-07	4.42e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	2.87e-07	4.42e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.86e-07	4.41e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.85e-07	4.39e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	2.83e-07	4.36e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.82e-07	4.35e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	2.81e-07	4.34e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.8e-07	4.32e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	2.8e-07	4.31e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.79e-07	4.3e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	2.76e-07	4.26e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	2.75e-07	4.24e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.75e-07	4.24e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.71e-07	4.18e-06	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.71e-07	4.18e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.69e-07	4.14e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	2.69e-07	4.14e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—POMC—epilepsy syndrome	2.68e-07	4.14e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.67e-07	4.12e-06	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.67e-07	4.11e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	2.66e-07	4.11e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	2.66e-07	4.11e-06	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.66e-07	4.1e-06	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.65e-07	4.09e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	2.65e-07	4.09e-06	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.64e-07	4.08e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.64e-07	4.07e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.64e-07	4.06e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.63e-07	4.05e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.62e-07	4.04e-06	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.62e-07	4.04e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.61e-07	4.03e-06	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.61e-07	4.03e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	2.61e-07	4.02e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.6e-07	4e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.59e-07	4e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.59e-07	3.99e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.58e-07	3.98e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	2.58e-07	3.98e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.57e-07	3.96e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.56e-07	3.95e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.55e-07	3.94e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.55e-07	3.93e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.54e-07	3.92e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.54e-07	3.91e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.54e-07	3.91e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.53e-07	3.9e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.52e-07	3.88e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.51e-07	3.87e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.51e-07	3.87e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.51e-07	3.87e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.51e-07	3.87e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.51e-07	3.87e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.5e-07	3.85e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.49e-07	3.85e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.49e-07	3.84e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.48e-07	3.83e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.48e-07	3.82e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.48e-07	3.82e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.47e-07	3.81e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.46e-07	3.79e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.45e-07	3.78e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ALB—epilepsy syndrome	2.45e-07	3.77e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.44e-07	3.77e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—epilepsy syndrome	2.44e-07	3.77e-06	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.43e-07	3.74e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.42e-07	3.73e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.42e-07	3.73e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.41e-07	3.72e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.41e-07	3.71e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.4e-07	3.71e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.4e-07	3.7e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.38e-07	3.67e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.37e-07	3.66e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	2.34e-07	3.61e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	2.33e-07	3.6e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.31e-07	3.56e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	2.3e-07	3.55e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.3e-07	3.54e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.29e-07	3.53e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.29e-07	3.53e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.28e-07	3.52e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	2.28e-07	3.51e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.27e-07	3.5e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.26e-07	3.48e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.25e-07	3.48e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.24e-07	3.46e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.24e-07	3.46e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.24e-07	3.45e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	2.24e-07	3.45e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	2.23e-07	3.45e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.23e-07	3.44e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.22e-07	3.43e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	2.22e-07	3.42e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.2e-07	3.4e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.2e-07	3.39e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.2e-07	3.38e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.19e-07	3.38e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	2.17e-07	3.35e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.14e-07	3.3e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.14e-07	3.3e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	2.14e-07	3.3e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	2.11e-07	3.25e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.09e-07	3.23e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.04e-07	3.15e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.04e-07	3.14e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.02e-07	3.12e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.02e-07	3.11e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2e-07	3.08e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.97e-07	3.03e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.95e-07	3.01e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-07	2.97e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.93e-07	2.97e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	1.92e-07	2.95e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	1.9e-07	2.93e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.72e-07	2.64e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.71e-07	2.64e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.7e-07	2.62e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.66e-07	2.55e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.65e-07	2.55e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-07	2.54e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.6e-07	2.47e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.58e-07	2.43e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.56e-07	2.4e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.51e-07	2.33e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-07	2.24e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.43e-07	2.21e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.43e-07	2.2e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-07	2.19e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-07	2.19e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.4e-07	2.17e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.4e-07	2.16e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.32e-07	2.03e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.3e-07	2.01e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—epilepsy syndrome	1.23e-07	1.89e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.1e-07	1.7e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.08e-07	1.66e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.01e-07	1.56e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.01e-07	1.55e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	8.59e-08	1.32e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.63e-08	1.02e-06	CbGpPWpGaD
